Healthy Human volunteers part of which clinical trial phases

**Core Concept**
Phase I clinical trials are primarily conducted in healthy human volunteers to evaluate the safety, pharmacokinetics, and pharmacodynamics of a new drug or treatment. This phase aims to identify the maximum tolerated dose, assess the drug's absorption, distribution, metabolism, and excretion (ADME), and establish a safe dosing regimen for further trials.

**Why the Correct Answer is Right**
Healthy volunteers are chosen for Phase I trials because they have a lower risk of adverse effects and are less likely to have underlying medical conditions that could complicate the study. The primary goal of Phase I trials is to gather information on the drug's safety profile, and healthy volunteers provide a controlled environment to assess this. The pharmacokinetic and pharmacodynamic studies conducted in Phase I trials help researchers understand how the drug is processed by the body, its potential side effects, and its efficacy in a controlled setting.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Phase II trials typically involve patients with the target disease or condition the treatment is intended to address, not healthy volunteers.
**Option B:** This option is incorrect because Phase III trials are conducted in a larger population to confirm the efficacy and safety of the treatment in a more diverse group of patients.
**Option C:** This option is incorrect because Phase IV trials are post-marketing studies that monitor the long-term safety and efficacy of a treatment in a large population.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that Phase I clinical trials are designed to assess the safety and tolerability of a new treatment, and healthy volunteers are chosen for this phase due to their lower risk of adverse effects.

**Correct Answer: A. Healthy human volunteers.**